NuGen Expands InsuJet™ Distribution Across Canada

NuGen Medical Devices Inc ( (TSE:NGMD) ) has shared an announcement.

NuGen Medical Devices Inc. has announced the expansion of its InsuJet™ distribution across Canada, following Health Canada approval and its introduction at World Diabetes Day in 2024. The device, which offers needle-free insulin administration, is now available through major Canadian pharmacy retailers and distributors. Partnerships with Sol-Millennium, MyRxCare, and Greenshield Canada aim to enhance accessibility and education for Canadians with diabetes. Sol-Millennium is also collaborating with I Challenge Diabetes to promote the technology and engage with healthcare professionals and families, with the goal of integrating InsuJet™ into the Canadian Diabetes Guidelines.

More about NuGen Medical Devices Inc

NuGen Medical Devices Inc. is a leading developer of needle-free devices for subcutaneous therapeutic administration. The company markets the InsuJet™ needle-free injection system, designed to improve the lives of diabetics, and has approval for sale in 42 countries globally.

YTD Price Performance: 28.57%

Average Trading Volume: 181,476

Technical Sentiment Signal: Hold

Current Market Cap: C$17.78M

For a thorough assessment of NGMD stock, go to TipRanks’ Stock Analysis page.